Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,490 across all filing types
Latest filing 2024-01-02 Major Shareholding Noti…
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Major Shareholding Notification Classification · 95% confidence The document is a monthly return report detailing movements in securities, specifically authorized and issued shares, share options, and other related share capital information for 3SBio Inc. It is addressed to the Hong Kong Exchanges and Clearing Limited and covers the month ended 31 December 2023. The content focuses on share capital movements, share options, and confirmations related to securities issuance. There is no financial performance data, earnings information, or management discussion. The document is regulatory in nature, reporting share capital and securities movements as required by the exchange rules. It is not an annual or interim report, earnings release, or management report. It is also not a proxy, voting result, or remuneration report. Given the detailed share capital movement data and the regulatory submission context, this fits best under Major Shareholding Notification (MRQ) as it reports on share capital and share option movements, which are significant shareholding-related disclosures under Hong Kong Exchange rules.
2024-01-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 December 2023. It details movements in authorised/registered share capital, issued shares, and confirms no changes in share options, warrants, convertibles, or other agreements. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance movements. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to share capital and securities movements, fitting the category of Regulatory Filings (RNS) as it does not fit other more specific categories and is a compliance document reporting share capital status and movements.
2024-01-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 November 2023. It details movements in authorised/registered share capital, issued shares, share options, and confirms no securities were issued during the month. The content focuses on share capital and share issuance movements, typical of regulatory filings related to share capital changes. It does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report but a regulatory submission about share capital movements. This fits the category of Share Issue/Capital Change (SHA).
2023-12-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2023
Share Issue/Capital Change Classification · 95% confidence The document is a monthly return report detailing movements in securities, specifically authorized and issued shares, for Hongkong Chinese Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and includes detailed tables on share capital and issued shares, with no mention of financial performance, earnings, or management commentary. The document is a regulatory submission related to share capital movements rather than a financial report or announcement of a report. It fits the category of Share Issue/Capital Change (SHA) as it reports on changes in share capital and issued shares.
2023-12-01 English
VOLUNTARY ANNOUNCEMENT OF 3SBIO INC. -3SBIO INC.HAS ENTERED INTO LICENSING AGREEMENT WITH CSTONE PHARMACEUTICALS IN RESPECT OF ANTI-PD-1 MONOCLONAL ANTIBODY NOFAZINLIMAB
Capital/Financing Update Classification · 95% confidence The document is a voluntary announcement by 3SBio Inc. regarding entering into a licensing agreement with CStone Pharmaceuticals for an anti-PD-1 monoclonal antibody. It includes details about the agreement terms, clinical study progress, and company background. There are no financial statements, quarterly or annual results, or detailed financial analysis. The document is an announcement of a business collaboration/licensing deal rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or M&A filings. It is a voluntary announcement about a licensing agreement, which aligns best with Capital/Financing Update (CAP) as it relates to company financing and business development activities involving payments and royalties. The document length is substantial and contains detailed information about the agreement and clinical data, supporting a confident classification as CAP rather than a brief announcement or regulatory filing.
2023-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 October 2023. It details movements in authorized/registered share capital, issued shares, share options, and confirms no securities were issued during the month. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share movements. It does not contain financial statements, earnings data, or management commentary. It is a regulatory filing related to share capital movements and compliance with listing rules, not a financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS).
2023-11-01 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.